Oxomidazopyridine-carboxamides
US6723332B2 · kind B2 · utility
10Cited by
0References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2001 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | May 24, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formula: wherein:A, B, C, E, F, and G are substituents as defined herein, which compounds bind to the benzodiazepine site of GABAA receptors and are therefore useful in treatment of central nervous system (CNS) diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.